Skip to main content
. Author manuscript; available in PMC: 2019 Jun 3.
Published in final edited form as: J Subst Abuse Treat. 2019 Jan 30;100:45–51. doi: 10.1016/j.jsat.2019.01.021

Table 3.

Factors associated with HCV treatment (n = 124).

Characteristic HCV untreated N = 100 N (%) HCV treated N = 24 N (%) Uni-variable odds ratio 95% CI Multi-variable odds ratio 95% CI
Median age (years) 51.5 (44−58) 54.5 (49−57) 1.03 0.98−1.08 1.03 0.96−1.2
Male 58 (58) 12 (50) 0.72 0.30−1.77 0.42 0.14−1.19
African American 64 (64) 19 (79) 2.14 0.74−6.21 0.90 0.22−3.70
HIV infected 15 (15) 9 (38) 3.40 1.269.17 2.27 0.72−7.16
*Recent drug use 68(68) 11(46) 0.40 0.160.99 0.39 0.14−1.06
Hazardous alcohol use 30 (30) 9 (38) 1.4 0.55−3.55
Primary care provider 83 (83) 21 (88) 1.43 0.38−5.35
Aware of DAA effectiveness 67 (67) 18 (75) 1.77 0.61−5.19
Have a friend that died of liver disease 56(56) 13(54) 1.70 0.82−3.49
Have a partner or friend concerned about their HCV 53 (53) 19 (79) 3.37 1.169.73 5.02 1.417.67

Note: Significant factors highlighted in bold text.

*

Recent drug use defined as any illicit drug use in the preceding 6 months.

*

Hazardous alcohol use defined as an AUDIT-C score of ≥ 4 for men and ≥ 3 for women.